|
|
||||||||||||||
|
|
|||||||||||||||
Therapeutics |
Clinical impact ratings GP/FP/Primary care






Internal medicine 





Cardiology 





Respirology 





Key Words: behaviour therapy bupropion cardiovascular diseases directive counselling dopamine uptake inhibitors smoking cessation
| The first 150 words of the full text of this article appear below. |
METHODS
Design:
randomised controlled trial.
Allocation:
{not concealed*}
.
Blinding:
unblinded.*
Follow up period:
2 years.
Setting:
coronary care unit in a university hospital in Nebraska, USA.
Patients:
209 patients 30–75 years of age (mean age 55 y, 63% men) who were admitted to the coronary care unit with acute coronary syndrome or decompensated heart failure, had smoked for
5 years, and had a Fagerstrom score >7. Exclusion criteria included current alcohol or illicit substance addiction.
Intervention:
an intensive smoking cessation intervention plus usual care (n = 109) or usual care only (n = 100). The intensive intervention included weekly 60 minute counselling sessions for
3 months after discharge and individualised nicotine replacement therapy and/or bupropion at no cost. Intervention group patients were re-treated if they started smoking again. Usual care included written self help materials and a 30 minute counselling session before discharge.
Outcomes:
point prevalence (no smoking since
Charles J Bentz, MD, FACP
Providence, St Vincent Hospital and Medical Center, Portland, Oregon,
USA
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |